IL149314A0 - Agent for treating hepatitis c - Google Patents

Agent for treating hepatitis c

Info

Publication number
IL149314A0
IL149314A0 IL14931401A IL14931401A IL149314A0 IL 149314 A0 IL149314 A0 IL 149314A0 IL 14931401 A IL14931401 A IL 14931401A IL 14931401 A IL14931401 A IL 14931401A IL 149314 A0 IL149314 A0 IL 149314A0
Authority
IL
Israel
Prior art keywords
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
IL14931401A
Other languages
English (en)
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of IL149314A0 publication Critical patent/IL149314A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14931401A 2000-03-22 2001-03-20 Agent for treating hepatitis c IL149314A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain

Publications (1)

Publication Number Publication Date
IL149314A0 true IL149314A0 (en) 2002-11-10

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14931401A IL149314A0 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c

Country Status (17)

Country Link
JP (1) JP2003527414A (xx)
KR (1) KR20020087045A (xx)
CN (1) CN1416347A (xx)
AT (1) AT408719B (xx)
AU (1) AU2001239000A1 (xx)
BG (1) BG107088A (xx)
BR (1) BR0107211A (xx)
CA (1) CA2389173A1 (xx)
EA (1) EA200200584A1 (xx)
HR (1) HRP20020367A2 (xx)
IL (1) IL149314A0 (xx)
IS (1) IS6360A (xx)
MA (1) MA25509A1 (xx)
MX (1) MXPA02004993A (xx)
NO (1) NO20022253L (xx)
PL (1) PL365000A1 (xx)
WO (1) WO2001070203A2 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2008039179A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
PL365000A1 (en) 2004-12-27
AT408719B (de) 2002-02-25
WO2001070203A2 (de) 2001-09-27
MA25509A1 (fr) 2002-07-01
NO20022253D0 (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
HRP20020367A2 (en) 2004-02-29
AU2001239000A1 (en) 2001-10-03
WO2001070203A3 (de) 2002-09-06
IS6360A (is) 2002-04-24
EA200200584A1 (ru) 2003-06-26
BG107088A (en) 2003-05-30
CA2389173A1 (en) 2001-09-27
BR0107211A (pt) 2004-01-06
ATA4812000A (de) 2001-07-15
JP2003527414A (ja) 2003-09-16
CN1416347A (zh) 2003-05-07
KR20020087045A (ko) 2002-11-21
NO20022253L (no) 2002-05-10

Similar Documents

Publication Publication Date Title
EP1346724A4 (en) REMEDIES FOR HEPATITIS C
GB0011120D0 (en) Process
PL362855A1 (en) Improved treatment
GB0013793D0 (en) Process
GB0010437D0 (en) Process
EG24462A (en) Compounds for treating fundic disaccomodation
GB0002201D0 (en) Process
AU1603401A (en) Pyranoindoles for treating glaucoma
IL149314A0 (en) Agent for treating hepatitis c
GB0014583D0 (en) Process
GB0123898D0 (en) Method for treating objects
GB0118883D0 (en) Method for treating objects
EP1291461A4 (en) COLOR RECOVERY FUNDS
GB0007652D0 (en) Treatment for fabrics
GB0122810D0 (en) Method for treating objects
GB0123897D0 (en) Method for treating objects
EP1253930A4 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CANCER
GB0026838D0 (en) Treatment method
GB0013791D0 (en) Process
GB0030956D0 (en) Stain treatment composition
GB0031321D0 (en) Treatment
EP1335734A4 (en) METHOD FOR TREATING HIV
GB0007665D0 (en) Treatment for fabrics
GB0006722D0 (en) Process
GB0001564D0 (en) Process